Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ginkgo Bioworks Hldgs Inc 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 USA

www.ginkgobioworks.com Employees: 834 P: 877-442-5362

Sector:

Medical

Description:

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 558,640
Enterprise Value, $K -2,930
Shares Outstanding, K 60,590
Float, K 54,701
% Float 90.28%
Short Interest, K 6,698
Short Float 11.05%
Days to Cover 8.36
Short Volume Ratio 0.46
% of Insider Shareholders 9.72%
% of Institutional Shareholders 78.63%

Financials:

Annual Sales, $ 227,040 K
Annual Net Income, $ -547,030 K
Last Quarter Sales, $ 38,840 K
Last Quarter Net Income, $ -80,760 K
EBIT, $ -348,140 K
EBITDA, $ -237,260 K

Growth:

1-Year Return -19.34%
3-Year Return -84.32%
5-Year Return 0.00%
5-Year Revenue Growth 319.05%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.45 on 11/06/25
Next Earnings Date 02/26/26 [AMC]
Earnings Per Share ttm -5.95
EPS Growth vs. Prev Qtr -31.82%
EPS Growth vs. Prev Year -34.26%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 08/20/24

DNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.15%
Return-on-Assets % -25.48%
Profit Margin % -240.94%
Debt/Equity 0.00
Price/Sales 2.79
Price/Cash Flow N/A
Price/Book 0.98
Book Value/Share 9.85
Interest Coverage -6,082.44
60-Month Beta 1.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar